trending Market Intelligence /marketintelligence/en/news-insights/trending/Tvye0Pk89JxrG9cQufqPUQ2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Dimension Therapeutics adds director

Blog

Global M&A Infographic Q1 2021

Blog

Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge

Blog

COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


Dimension Therapeutics adds director

Dimension Therapeutics Inc. appointed John Hohneker, an executive vice president and head of research and development at FORMA Therapeutics Inc., to its board of directors, effective Jan. 18.

Hohneker will serve as a class 1 director until Dimension's next annual stockholders' meeting following Dec. 31, 2018.